Absztrakt: Az utóbbi néhány évtized klinikai előrelépéseinek köszönhetően az akut
lymphoblastos leukaemiás (ALL-) gyermekek nagy hányada ma az első vonalbeli …

Owing to clinical trials and improvement over the past few decades, the majority of children
with acute lymphoblastic leukemia (ALL) survive by first-line chemotherapy and combat with …

In recent decades, survival rates for childhood acute lymphoblastic leukemia have improved
remarkably, as demonstrated by risk-stratified, prospective multicenter studies. Treatment …

Acute lymphoblastic leukemia (ALL) is the most common malignancy of childhood and has
served as a model system for clinical and basic research beyond pediatric hemato-oncology …

The development of effective therapy for children with acute lymphoblastic leukemia is one
of the great successes of clinical hematology andoncology. Fifty years ago, childhood acute …

Introduction Acute lymphoblastic leukemia is the most frequent hematologic malignancy in
children. Almost 95% of children potentially achieve a complete remission after the induction …

Childhood acute lymphoblastic leukemia is a model in oncology. The outcome was dismal
40 years ago but is now generally excellent, owing to the recent advent of new drugs. These …

Acute lymphoblastic leukemia (ALL) is the most common malignancy of childhood and is
treated with chemotherapy alone or, in particular subgroups, with additional radiation …

The cure rate of acute lymphoblastic leukemia (ALL) in children dramatically improved over
past 5 decades from zero to about 80%. The main cause of improvement is owing to the …

Acute lymphoblastic leukemia (ALL) accounts for a quarter of malignant neoplasms in
children and adolescents. With continuous effort on developing risk-stratified multi-agent …